3-Cyclohexene-1-carbonitrile, 3,5-dimethyl-
Common Name: |
3-Cyclohexene-1-carbonitrile, 3,5-dimethyl- |
IUPAC Name: |
3,5-dimethylcyclohex-3-ene-1-carbonitrile |
Molecular Formula: |
C9H13N |
SMILES: |
CC1CC(CC(=C1)C)C#N |
Inchi: |
1S/C9H13N/c1-7-3-8(2)5-9(4-7)6-10/h3,7,9H,4-5H2,1-2H3 |
Inchi Key: |
PHYAMLKALRTMOP-UHFFFAOYSA-N |
Cas No: |
66848-40-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
135.21 |
Mass (g/mol) |
135.105 |
Molar Refractivity |
42.54 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
0 |
Rings |
1 |
TPSA |
23.79 |
Hetero Atoms |
1 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
221.00 to 223.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.097 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.67 |
LogP |
2.502 |
iLOGP |
2.09 |
XLOGP3 |
1.71 |
WLOGP |
2.50 |
MLOGP |
1.89 |
ESOL Log S |
-1.76 |
ESOL Solubility (mg/ml) |
2.37 |
ESOL Solubility (mol/l) |
0.018 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.83 |
Ali Solubility (mg/ml) |
2.02 |
Ali Solubility (mol/l) |
0.02 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.67 |
Silicos-IT Solubility (mg/ml) |
2.92 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.91 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.515 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.889 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |